 | • レポートコード：QYR2104Z2271 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、エクソソームのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ノンコーディングRNA、脂質、mRNA、DNA断片、タンパク質/ペプチド）、用途別市場規模（がん、感染症、神経変性疾患、循環器疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エクソソームの市場動向 ・企業の競争状況、市場シェア ・エクソソームの種類別市場規模（ノンコーディングRNA、脂質、mRNA、DNA断片、タンパク質/ペプチド） ・エクソソームの用途別市場規模（がん、感染症、神経変性疾患、循環器疾患） ・エクソソームの北米市場規模2016-2027（アメリカ、カナダ） ・エクソソームのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エクソソームのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エクソソームの中南米市場規模2016-2027（メキシコ、ブラジル） ・エクソソームの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Fujifilm、Thermo Fisher Scientific、Danaher、Illumina、Qiagen、Takara Bio、Malvern Instruments、Miltenyi Biotec、MBL International、Lonza） ・結論 |
Market Analysis and Insights: Global Exosomes Market
The global Exosomes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosomes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosomes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosomes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosomes market.
Global Exosomes Scope and Market Size
Exosomes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exosomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides
Segment by Application
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosomes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-coding RNAs
1.2.3 Lipids
1.2.4 mRNA
1.2.5 DNA fragments
1.2.6 Proteins /peptides
1.3 Market by Application
1.3.1 Global Exosomes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Infectious diseases
1.3.4 Neurodegenerative diseases
1.3.5 Cardiovascular diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exosomes Market Perspective (2016-2027)
2.2 Exosomes Growth Trends by Regions
2.2.1 Exosomes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exosomes Historic Market Share by Regions (2016-2021)
2.2.3 Exosomes Forecasted Market Size by Regions (2022-2027)
2.3 Exosomes Industry Dynamic
2.3.1 Exosomes Market Trends
2.3.2 Exosomes Market Drivers
2.3.3 Exosomes Market Challenges
2.3.4 Exosomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosomes Players by Revenue
3.1.1 Global Top Exosomes Players by Revenue (2016-2021)
3.1.2 Global Exosomes Revenue Market Share by Players (2016-2021)
3.2 Global Exosomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exosomes Revenue
3.4 Global Exosomes Market Concentration Ratio
3.4.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2020
3.5 Exosomes Key Players Head office and Area Served
3.6 Key Players Exosomes Product Solution and Service
3.7 Date of Enter into Exosomes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosomes Breakdown Data by Type
4.1 Global Exosomes Historic Market Size by Type (2016-2021)
4.2 Global Exosomes Forecasted Market Size by Type (2022-2027)
5 Exosomes Breakdown Data by Application
5.1 Global Exosomes Historic Market Size by Application (2016-2021)
5.2 Global Exosomes Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Exosomes Market Size (2016-2027)
6.2 North America Exosomes Market Size by Type
6.2.1 North America Exosomes Market Size by Type (2016-2021)
6.2.2 North America Exosomes Market Size by Type (2022-2027)
6.2.3 North America Exosomes Market Size by Type (2016-2027)
6.3 North America Exosomes Market Size by Application
6.3.1 North America Exosomes Market Size by Application (2016-2021)
6.3.2 North America Exosomes Market Size by Application (2022-2027)
6.3.3 North America Exosomes Market Size by Application (2016-2027)
6.4 North America Exosomes Market Size by Country
6.4.1 North America Exosomes Market Size by Country (2016-2021)
6.4.2 North America Exosomes Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Exosomes Market Size (2016-2027)
7.2 Europe Exosomes Market Size by Type
7.2.1 Europe Exosomes Market Size by Type (2016-2021)
7.2.2 Europe Exosomes Market Size by Type (2022-2027)
7.2.3 Europe Exosomes Market Size by Type (2016-2027)
7.3 Europe Exosomes Market Size by Application
7.3.1 Europe Exosomes Market Size by Application (2016-2021)
7.3.2 Europe Exosomes Market Size by Application (2022-2027)
7.3.3 Europe Exosomes Market Size by Application (2016-2027)
7.4 Europe Exosomes Market Size by Country
7.4.1 Europe Exosomes Market Size by Country (2016-2021)
7.4.2 Europe Exosomes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Exosomes Market Size (2016-2027)
8.2 Asia-Pacific Exosomes Market Size by Type
8.2.1 Asia-Pacific Exosomes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exosomes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exosomes Market Size by Type (2016-2027)
8.3 Asia-Pacific Exosomes Market Size by Application
8.3.1 Asia-Pacific Exosomes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exosomes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exosomes Market Size by Application (2016-2027)
8.4 Asia-Pacific Exosomes Market Size by Region
8.4.1 Asia-Pacific Exosomes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exosomes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exosomes Market Size (2016-2027)
9.2 Latin America Exosomes Market Size by Type
9.2.1 Latin America Exosomes Market Size by Type (2016-2021)
9.2.2 Latin America Exosomes Market Size by Type (2022-2027)
9.2.3 Latin America Exosomes Market Size by Type (2016-2027)
9.3 Latin America Exosomes Market Size by Application
9.3.1 Latin America Exosomes Market Size by Application (2016-2021)
9.3.2 Latin America Exosomes Market Size by Application (2022-2027)
9.3.3 Latin America Exosomes Market Size by Application (2016-2027)
9.4 Latin America Exosomes Market Size by Country
9.4.1 Latin America Exosomes Market Size by Country (2016-2021)
9.4.2 Latin America Exosomes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosomes Market Size (2016-2027)
10.2 Middle East & Africa Exosomes Market Size by Type
10.2.1 Middle East & Africa Exosomes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exosomes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exosomes Market Size by Type (2016-2027)
10.3 Middle East & Africa Exosomes Market Size by Application
10.3.1 Middle East & Africa Exosomes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exosomes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exosomes Market Size by Application (2016-2027)
10.4 Middle East & Africa Exosomes Market Size by Country
10.4.1 Middle East & Africa Exosomes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exosomes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fujifilm
11.1.1 Fujifilm Company Details
11.1.2 Fujifilm Business Overview
11.1.3 Fujifilm Exosomes Introduction
11.1.4 Fujifilm Revenue in Exosomes Business (2016-2021)
11.1.5 Fujifilm Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Exosomes Introduction
11.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Exosomes Introduction
11.3.4 Danaher Revenue in Exosomes Business (2016-2021)
11.3.5 Danaher Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Exosomes Introduction
11.4.4 Illumina Revenue in Exosomes Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Exosomes Introduction
11.5.4 Qiagen Revenue in Exosomes Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Details
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Exosomes Introduction
11.6.4 Takara Bio Revenue in Exosomes Business (2016-2021)
11.6.5 Takara Bio Recent Development
11.7 Malvern Instruments
11.7.1 Malvern Instruments Company Details
11.7.2 Malvern Instruments Business Overview
11.7.3 Malvern Instruments Exosomes Introduction
11.7.4 Malvern Instruments Revenue in Exosomes Business (2016-2021)
11.7.5 Malvern Instruments Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Details
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec Exosomes Introduction
11.8.4 Miltenyi Biotec Revenue in Exosomes Business (2016-2021)
11.8.5 Miltenyi Biotec Recent Development
11.9 MBL International
11.9.1 MBL International Company Details
11.9.2 MBL International Business Overview
11.9.3 MBL International Exosomes Introduction
11.9.4 MBL International Revenue in Exosomes Business (2016-2021)
11.9.5 MBL International Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Exosomes Introduction
11.10.4 Lonza Revenue in Exosomes Business (2016-2021)
11.10.5 Lonza Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Exosomes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-coding RNAs
Table 3. Key Players of Lipids
Table 4. Key Players of mRNA
Table 5. Key Players of DNA fragments
Table 6. Key Players of Proteins /peptides
Table 7. Global Exosomes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Exosomes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Exosomes Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Exosomes Market Share by Regions (2016-2021)
Table 11. Global Exosomes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Exosomes Market Share by Regions (2022-2027)
Table 13. Exosomes Market Trends
Table 14. Exosomes Market Drivers
Table 15. Exosomes Market Challenges
Table 16. Exosomes Market Restraints
Table 17. Global Exosomes Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Exosomes Market Share by Players (2016-2021)
Table 19. Global Top Exosomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosomes as of 2020)
Table 20. Ranking of Global Top Exosomes Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Exosomes Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Exosomes Product Solution and Service
Table 24. Date of Enter into Exosomes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Exosomes Revenue Market Share by Type (2016-2021)
Table 28. Global Exosomes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Exosomes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Exosomes Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Exosomes Revenue Market Share by Application (2016-2021)
Table 32. Global Exosomes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Exosomes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Exosomes Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Exosomes Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Exosomes Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Exosomes Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Exosomes Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Exosomes Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Exosomes Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Exosomes Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Exosomes Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Exosomes Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Exosomes Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Exosomes Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Exosomes Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Exosomes Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Exosomes Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Exosomes Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Exosomes Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Exosomes Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Exosomes Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Exosomes Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Exosomes Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Exosomes Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Exosomes Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Exosomes Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Exosomes Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Exosomes Market Size by Country (2022-2027) & (US$ Million)
Table 64. Fujifilm Company Details
Table 65. Fujifilm Business Overview
Table 66. Fujifilm Exosomes Product
Table 67. Fujifilm Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 68. Fujifilm Recent Development
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Exosomes Product
Table 72. Thermo Fisher Scientific Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Danaher Company Details
Table 75. Danaher Business Overview
Table 76. Danaher Exosomes Product
Table 77. Danaher Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 78. Danaher Recent Development
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Exosomes Product
Table 82. Illumina Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 83. Illumina Recent Development
Table 84. Qiagen Company Details
Table 85. Qiagen Business Overview
Table 86. Qiagen Exosomes Product
Table 87. Qiagen Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 88. Qiagen Recent Development
Table 89. Takara Bio Company Details
Table 90. Takara Bio Business Overview
Table 91. Takara Bio Exosomes Product
Table 92. Takara Bio Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 93. Takara Bio Recent Development
Table 94. Malvern Instruments Company Details
Table 95. Malvern Instruments Business Overview
Table 96. Malvern Instruments Exosomes Product
Table 97. Malvern Instruments Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 98. Malvern Instruments Recent Development
Table 99. Miltenyi Biotec Company Details
Table 100. Miltenyi Biotec Business Overview
Table 101. Miltenyi Biotec Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 102. Miltenyi Biotec Recent Development
Table 103. MBL International Company Details
Table 104. MBL International Business Overview
Table 105. MBL International Exosomes Product
Table 106. MBL International Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 107. MBL International Recent Development
Table 108. Lonza Company Details
Table 109. Lonza Business Overview
Table 110. Lonza Exosomes Product
Table 111. Lonza Revenue in Exosomes Business (2016-2021) & (US$ Million)
Table 112. Lonza Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosomes Market Share by Type: 2020 VS 2027
Figure 2. Non-coding RNAs Features
Figure 3. Lipids Features
Figure 4. mRNA Features
Figure 5. DNA fragments Features
Figure 6. Proteins /peptides Features
Figure 7. Global Exosomes Market Share by Application: 2020 VS 2027
Figure 8. Cancer Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Neurodegenerative diseases Case Studies
Figure 11. Cardiovascular diseases Case Studies
Figure 12. Exosomes Report Years Considered
Figure 13. Global Exosomes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Exosomes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Exosomes Market Share by Regions: 2020 VS 2027
Figure 16. Global Exosomes Market Share by Regions (2022-2027)
Figure 17. Global Exosomes Market Share by Players in 2020
Figure 18. Global Top Exosomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosomes as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Exosomes Revenue in 2020
Figure 20. Global Exosomes Revenue Market Share by Type (2016-2021)
Figure 21. Global Exosomes Revenue Market Share by Type (2022-2027)
Figure 22. North America Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Exosomes Market Share by Type (2016-2027)
Figure 24. North America Exosomes Market Share by Application (2016-2027)
Figure 25. North America Exosomes Market Share by Country (2016-2027)
Figure 26. United States Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Exosomes Market Share by Type (2016-2027)
Figure 30. Europe Exosomes Market Share by Application (2016-2027)
Figure 31. Europe Exosomes Market Share by Country (2016-2027)
Figure 32. Germany Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Exosomes Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Exosomes Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Exosomes Market Share by Region (2016-2027)
Figure 42. China Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Exosomes Market Share by Type (2016-2027)
Figure 50. Latin America Exosomes Market Share by Application (2016-2027)
Figure 51. Latin America Exosomes Market Share by Country (2016-2027)
Figure 52. Mexico Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Exosomes Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Exosomes Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Exosomes Market Share by Country (2016-2027)
Figure 58. Turkey Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Exosomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Fujifilm Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 63. Danaher Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 64. Illumina Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 65. Qiagen Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 66. Takara Bio Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 67. Malvern Instruments Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 68. Miltenyi Biotec Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 69. MBL International Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 70. Lonza Revenue Growth Rate in Exosomes Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の神経変性疾患治療薬市場規模・現状・予測（2021年-2027年） Neurodegenerative disease is caused by the loss of neurons and/or their myelin sheath, which worsens over time and becomes dysfunctional. Market Analysis and Insights: Global Neurodegenerative Diseases Drug Market The global Neurodegenerative Diseases Drug market size is projected to reach US$ XX m…- 世界のPOC感染症市場規模・現状・予測（2021年-2027年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 世界の感染症市場規模・現状・予測（2021年-2027年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…
- 世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with br…
- 世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…